In the recent past, the introduction of SPECT cameras using digital cadmium zinc telluride (CZT) detectors has been one of the advancements in the SPECT equipment market. These replace the conventional photomultiplier tubes (PMTs) that have been the industry standard for years. CZT detectors are smaller, which decreases the size of SPECT systems, making them handier. Moreover, CZT detectors provide improved image quality with direct digital transfer of photons into electrical signals to create images. The detectors are more sensitive than PMT-based cameras; hence, they enable examination with half the amount of radiotracers used by traditional cameras. Alternatively, the dose that is commonly used can be one of the viable option and the imaging time can be reduced by 50%, known as half-time imaging, which is one of the restraining factors associated with radiopharmaceuticals in general. The use of fewer radiotracers is also attractive from a supply standpoint, lowering operational costs and because there have been shortages of some SPECT radioisotopes over the past few years. Hybrid systems that integrate a computed tomography (CT) scanner for PET-CT and SPECT-CT systems have become more popular in the market in recent times. These combined systems use CT for attenuation correct on the nuclear images, while adding CT anatomical image overlays improves the diagnosis accuracy to a greater extent, by visualizing the coronary anatomy to better pinpoint where blockages are causing perfusion defects.
The severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) spread rapidly around the world in the early months of 2020 before the COVID-19 outbreak was officially declared a pandemic in March 2020. Worldwide volumes of non-emergent testing, such as cardiac SPECT, decreased dramatically at the beginning of the lockdown as health systems attempted to limit the spread of the COVID-19 virus. Countries in Asia Pacific are facing challenges due to increasing incidences of COVID-19. As per the data of Worldometer, as of June 23, 2021, the Asia reported a total of 54.7 million COVID-19 cases, while in India the number of cases has been increasing and reached to 30,028,709 cases with 390,691 deaths so far. China, India and Japan registered considerable number of COVID-19 cases. The medical practices in the region continue to adapt to the challenges of CsOVID-19. Hospitals and other healthcare facilities worldwide are forced to postpone elective procedures, such as diagnosis and surgeries. Most non-urgent therapies have been postponed. As a precautionary approach, oncology practices implemented specific measures to reduce the number of patients in outpatient clinics, reduce unnecessary or elective procedures, and discharge patients from inpatient services. This has negatively impacted the growth of the SPECT equipment market in the region. The COVID-19 is having a detrimental effect on cancer patients worldwide. In addition, market players have also been affected by the pandemic owing to supply chain contrarians and reduced demand. Even before the pandemic, Nuclear Medicine’s supply chain was highly complex, depending on the availability of raw materials, manufacturing facilities' operations, and air transportation reliability. Thus, the factors mentioned above are negatively impacting the SPECT Equipment market in the region.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SPECT equipment market. The APAC SPECT equipment is expected to grow at a good CAGR during the forecast period.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 284.60 Million |
| Market Size by 2028 | US$ 406.20 Million |
| CAGR (2021 - 2028) | 5.2% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific SPECT Equipment Market is valued at US$ 284.60 Million in 2021, it is projected to reach US$ 406.20 Million by 2028.
As per our report Asia Pacific SPECT Equipment Market, the market size is valued at US$ 284.60 Million in 2021, projecting it to reach US$ 406.20 Million by 2028. This translates to a CAGR of approximately 5.2% during the forecast period.
The Asia Pacific SPECT Equipment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific SPECT Equipment Market report:
The Asia Pacific SPECT Equipment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific SPECT Equipment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific SPECT Equipment Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific SPECT Equipment Market
